• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制作用与底物识别——一种应用于HIV蛋白酶的计算方法

Inhibition and substrate recognition--a computational approach applied to HIV protease.

作者信息

Vinkers H M, de Jonge M R, Daeyaert E D, Heeres J, Koymans L M H, van Lenthe J H, Lewi P J, Timmerman H, Janssen P A J

机构信息

Center for Molecular Design, Janssen Pharmaceutica N.V., Antwerpsesteenweg 37, B-2350 Vosselaar, Belgium.

出版信息

J Comput Aided Mol Des. 2003 Sep;17(9):567-81. doi: 10.1023/b:jcam.0000005748.19093.e8.

DOI:10.1023/b:jcam.0000005748.19093.e8
PMID:14713189
Abstract

We have developed a computational approach in which an inhibitor's strength is determined from its interaction energy with a limited set of amino acid residues of the inhibited protein. We applied this method to HIV protease. The method uses a consensus structure built from X-ray crystallographic data. All inhibitors are docked into the consensus structure. Given that not every ligand-protein interaction causes inhibition, we implemented a genetic algorithm to determine the relevant set of residues. The algorithm optimizes the q2 between the sum of interaction energies and the observed inhibition constants. The best possible predictive model resulting has a q2 of 0.63. External validation by examining the predictivity for compounds not used in derivation of the model leads to a prediction accuracy between 0.9 and 1.5 log10 unit. Out of 198 residues in the whole protein, the best internally predictive model defines a subset of 20 residues and the best externally predictive model one of 9 residues. These residues are distributed over the subsites of the enzyme. This approach provides insight in which interactions are important for inhibiting HIV protease and it allows for quantitative prediction of inhibitor strength.

摘要

我们开发了一种计算方法,通过抑制剂与被抑制蛋白的有限氨基酸残基集之间的相互作用能来确定抑制剂的强度。我们将此方法应用于HIV蛋白酶。该方法使用由X射线晶体学数据构建的共有结构。所有抑制剂都对接至该共有结构中。鉴于并非每个配体-蛋白质相互作用都会导致抑制作用,我们实施了一种遗传算法来确定相关的残基集。该算法优化了相互作用能总和与观察到的抑制常数之间的q2。由此得到的最佳预测模型的q2为0.63。通过检查对模型推导中未使用的化合物的预测能力进行外部验证,预测准确度在0.9至1.5个log10单位之间。在整个蛋白质的198个残基中,最佳内部预测模型定义了一个由20个残基组成的子集,最佳外部预测模型定义了一个由9个残基组成的子集。这些残基分布在酶的亚位点上。这种方法有助于深入了解哪些相互作用对于抑制HIV蛋白酶很重要,并且能够对抑制剂强度进行定量预测。

相似文献

1
Inhibition and substrate recognition--a computational approach applied to HIV protease.抑制作用与底物识别——一种应用于HIV蛋白酶的计算方法
J Comput Aided Mol Des. 2003 Sep;17(9):567-81. doi: 10.1023/b:jcam.0000005748.19093.e8.
2
Evaluation of the substrate envelope hypothesis for inhibitors of HIV-1 protease.对HIV-1蛋白酶抑制剂的底物包膜假说的评估。
Proteins. 2007 Aug 1;68(2):561-7. doi: 10.1002/prot.21431.
3
Integrating Multiple Receptor Conformation Docking and Multi Dimensional QSAR for Enhancing Accuracy of Binding Affinity Prediction.整合多种受体构象对接和多维定量构效关系以提高结合亲和力预测的准确性。
Curr Comput Aided Drug Des. 2017;13(2):127-142. doi: 10.2174/1573409913666170119115841.
4
Structure based design: novel spirocyclic ethers as nonpeptidal P2-ligands for HIV protease inhibitors.基于结构的设计:新型螺环醚作为HIV蛋白酶抑制剂的非肽类P2配体
Bioorg Med Chem Lett. 1998 Apr 21;8(8):979-82. doi: 10.1016/s0960-894x(98)00139-5.
5
Development of pseudopeptide inhibitors of HIV-1 aspartic protease: analysis and tuning of the subsite specificity.HIV-1天冬氨酸蛋白酶假肽抑制剂的开发:亚位点特异性的分析与调整
Pept Res. 1995 Nov-Dec;8(6):328-34.
6
Targeting the open-flap conformation of HIV-1 protease with pyrrolidine-based inhibitors.用基于吡咯烷的抑制剂靶向HIV-1蛋白酶的开放构象。
ChemMedChem. 2008 Sep;3(9):1337-44. doi: 10.1002/cmdc.200800113.
7
Potent cyclic urea HIV protease inhibitors with 3-aminoindazole P2/P2' groups.具有3-氨基吲唑P2/P2'基团的强效环脲HIV蛋白酶抑制剂。
Bioorg Med Chem Lett. 1998 Apr 7;8(7):715-20. doi: 10.1016/s0960-894x(98)00118-8.
8
Use of molecular dynamics and free energy perturbation calculations in anti-human immunodeficiency virus drug design.分子动力学和自由能扰动计算在抗人类免疫缺陷病毒药物设计中的应用。
Methods Enzymol. 1994;241:370-84. doi: 10.1016/0076-6879(94)41074-7.
9
Crystallographic analysis of human immunodeficiency virus 1 protease with an analog of the conserved CA-p2 substrate -- interactions with frequently occurring glutamic acid residue at P2' position of substrates.人类免疫缺陷病毒1型蛋白酶与保守的CA-p2底物类似物的晶体学分析——与底物P2'位置常见谷氨酸残基的相互作用。
Eur J Biochem. 1997 Oct 15;249(2):523-30. doi: 10.1111/j.1432-1033.1997.00523.x.
10
Design, synthesis, and X-ray crystallographic analysis of a novel class of HIV-1 protease inhibitors.新型 HIV-1 蛋白酶抑制剂的设计、合成与 X 射线晶体学分析。
J Med Chem. 2011 Oct 27;54(20):7176-83. doi: 10.1021/jm200778q. Epub 2011 Sep 26.

本文引用的文献

1
SYNOPSIS: SYNthesize and OPtimize System in Silico.摘要:在计算机模拟中合成并优化系统。
J Med Chem. 2003 Jun 19;46(13):2765-73. doi: 10.1021/jm030809x.
2
Further development and validation of empirical scoring functions for structure-based binding affinity prediction.基于结构的结合亲和力预测的经验评分函数的进一步开发与验证。
J Comput Aided Mol Des. 2002 Jan;16(1):11-26. doi: 10.1023/a:1016357811882.
3
Developing a methodology for an inverse quantitative structure-activity relationship using the signature molecular descriptor.
J Mol Graph Model. 2002 Jun;20(6):429-38. doi: 10.1016/s1093-3263(01)00144-9.
4
SMall Molecule Growth 2001 (SMoG2001): an improved knowledge-based scoring function for protein-ligand interactions.小分子生长2001(SMoG2001):一种用于蛋白质-配体相互作用的改进的基于知识的评分函数。
J Med Chem. 2002 Jun 20;45(13):2770-80. doi: 10.1021/jm0105833.
5
Consensus scoring for ligand/protein interactions.配体/蛋白质相互作用的共识评分
J Mol Graph Model. 2002 Jan;20(4):281-95. doi: 10.1016/s1093-3263(01)00125-5.
6
Beware of q2!小心q2!
J Mol Graph Model. 2002 Jan;20(4):269-76. doi: 10.1016/s1093-3263(01)00123-1.
7
A distinct binding mode of a hydroxyethylamine isostere inhibitor of HIV-1 protease.
Acta Crystallogr D Biol Crystallogr. 2001 Mar;57(Pt 3):472-6. doi: 10.1107/s0907444900018928.
8
Structural stability of binding sites: consequences for binding affinity and allosteric effects.结合位点的结构稳定性:对结合亲和力和变构效应的影响
Proteins. 2000;Suppl 4:63-71. doi: 10.1002/1097-0134(2000)41:4+<63::aid-prot60>3.3.co;2-y.
9
Synthesis, stability, antiviral activity, and protease-bound structures of substrate-mimicking constrained macrocyclic inhibitors of HIV-1 protease.
J Med Chem. 2000 Sep 21;43(19):3495-504. doi: 10.1021/jm000013n.
10
An alternate binding site for the P1-P3 group of a class of potent HIV-1 protease inhibitors as a result of concerted structural change in the 80s loop of the protease.由于蛋白酶80s环中协同的结构变化,一类强效HIV-1蛋白酶抑制剂的P1-P3基团的另一个结合位点。
Acta Crystallogr D Biol Crystallogr. 2000 Apr;56(Pt 4):381-8. doi: 10.1107/s0907444900000469.